Aksigorta A.S. (IST:AKGRT)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Investments	-	2,935	2,627	3,136	2,954	1,735
Total Investments	-	8,700	6,347	3,345	2,960	1,742
Cash & Equivalents	-	6,980	5,215	5,210	1,802	2,006
Reinsurance Recoverable	-	864.31	401.81	131.96	81.36	28.37
Other Receivables	-	4,977	6,446	2,783	1,495	1,114
Separate Account Assets	-	2.75	2.21	2.01	1.87	1.95
Property, Plant & Equipment	-	260.9	114.01	63.88	39.93	43.5
Other Intangible Assets	-	392.29	169.71	124.4	82.26	48.06
Restricted Cash	-	162.85	-	-	392.6	264.06
Other Current Assets	-	2,397	1,952	905.3	454.66	342.49
Long-Term Deferred Tax Assets	-	574.24	356.16	228.58	47.37	-
Other Long-Term Assets	-	244.9	128.34	43.76	30.45	9.23
Total Assets	-	25,556	21,132	12,837	7,388	5,600
Accounts Payable	-	-	-	-	72.05	26.54
Accrued Expenses	-	1,082	777.11	273.89	185.01	113.4
Insurance & Annuity Liabilities	-	1,131	610.6	311.44	244.94	151.29
Unpaid Claims	-	5,340	3,620	2,858	2,028	1,358
Unearned Premiums	-	7,854	7,062	4,429	2,249	1,777
Reinsurance Payable	-	4,208	5,156	2,053	1,244	765.63
Current Portion of Leases	-	26.65	28.6	18.93	14.97	7.38
Short-Term Debt	-	-	-	622.76	117.83	72.63
Current Income Taxes Payable	-	60.33	116.48	-	25.03	23.61
Long-Term Leases	-	143.2	28.58	27.03	12.6	21.51
Long-Term Deferred Tax Liabilities	-	-	-	-	-	5.68
Separate Account Liability	-	0.3	0.2	0.13	0.13	0.14
Other Current Liabilities	-	592.53	439.34	266.8	130.95	67
Total Liabilities	-	20,464	17,856	10,895	6,339	4,399
Common Stock	-	1,612	1,612	1,612	306	306
Additional Paid-In Capital	-	3.46	3.46	3.46	-	-
Retained Earnings	-	3,381	1,530	325.53	682.44	802.11
Comprehensive Income & Other	-	95.37	131.08	1.88	60.85	92.43
Shareholders' Equity	5,422	5,092	3,276	1,943	1,049	1,201
Total Liabilities & Equity	-	25,556	21,132	12,837	7,388	5,600
Filing Date Shares Outstanding	1,612	1,612	1,612	1,612	612	612
Total Common Shares Outstanding	1,612	1,612	1,612	1,612	612	612
Total Debt	189.44	169.84	57.18	668.72	145.4	101.52
Net Cash (Debt)	7,478	6,811	5,158	4,541	1,656	1,905
Net Cash Growth	-2.00%	32.05%	13.58%	174.15%	-13.03%	9.22%
Net Cash Per Share	4.64	4.22	3.20	2.82	2.71	3.11
Book Value Per Share	3.36	3.16	2.03	1.21	1.71	1.96
Tangible Book Value	4,850	4,700	3,107	1,818	967.03	1,152
Tangible Book Value Per Share	3.01	2.92	1.93	1.13	1.58	1.88
Machinery	-	114.02	67.43	54.24	33.14	33.15

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.